TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | -14.53% |
| Q3 2025 | -18.57% |
| Q2 2025 | -15.96% |
| Q1 2025 | -18.75% |
| Q4 2024 | 3.37% |
| Q3 2024 | -14.23% |
| Q2 2024 | 73.61% |
| Q1 2024 | -18.53% |
| Q4 2023 | -10.71% |
| Q3 2023 | -55.87% |
| Q2 2023 | 25.37% |
| Q1 2023 | -22.02% |
| Q4 2022 | -14.78% |
| Q3 2022 | -11.43% |
| Q2 2022 | -9.97% |
| Q1 2022 | -9.64% |
| Q4 2021 | -8.18% |
| Q3 2021 | 76.62% |
| Q2 2021 | -5.55% |
| Q1 2021 | 347.51% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |